Findings

What do systematic reviews say?

2,922 questions · 3,118 findings · 513 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 574 · 18.4%GRADE not reported 372 · 11.9%Very low 723 · 23.2%Low 854 · 27.4%Moderate 489 · 15.7%High 106 · 3.4%

Intervention not reported

Creatine phosphate 1g/day · patients with heart failure

1 finding from 1 review

Creatine and creatine analogues in hypertension and cardiovascular disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Low

Intervention not reported

Creatine 20g/day for 6 weeks · patients with heart failure

1 finding from 1 review

Creatine and creatine analogues in hypertension and cardiovascular disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Low

Intervention not reported

Creatine 20g/day for 10 days · patients with heart failure

1 finding from 1 review

Creatine and creatine analogues in hypertension and cardiovascular disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Intervention not reported

Creatinine phosphate 1g/day for 6 months · patients with heart failure

1 finding from 1 review

Creatine and creatine analogues in hypertension and cardiovascular disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 79 participants
Low

Intervention not reported

Creatinine phosphate 1g/day for 3 months · patients with heart failure

1 finding from 1 review

Creatine and creatine analogues in hypertension and cardiovascular disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 88 participants
Low

Intervention not reported

Peak exercise capacity: Power (W) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 367 participants
Moderate

Intervention not reported

Peak exercise capacity: Peak oxygen consumption (VO2peak) (L/min) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 188 participants
Moderate

Intervention not reported

Peak exercise test: Lactate threshold (L/min) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 94 participants
Moderate

Intervention not reported

Peak exercise test: Isowork minute ventilation (VE) (L) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 77 participants
Low

Intervention not reported

Peak exercise test: Isowork dyspnoea score · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Low

Intervention not reported

Exercise tolerance: Endurance time (min) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Low

Intervention not reported

Functional exercise capacity: Six‐minute walk distance (m) · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 287 participants
Low

Intervention not reported

Health‐related Quality of Life: Dyspnoea domain of the CRQ · people with chronic obstructive pulmonary disease

1 finding from 1 review

Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease 2011 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 212 participants
Moderate

Calcium channel blockers vs placebo/no treatment

Death · kidney transplant recipients

Calcium channel blockers showed no clear difference in death compared with placebo/no treatment (low certainty).

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
RR 0.82 [0.37, 1.82]
12 studies · 792 participants
Low

Angiotensin‐converting enzyme inhibitors vs placebo/no treatment

GFR · kidney transplant recipients

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 77 participants
Low

Angiotensin‐converting enzyme inhibitors vs placebo/no treatment

Proteinuria · kidney transplant recipients

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 175 participants
Moderate

Angiotensin‐converting enzyme inhibitors vs placebo/no treatment

Serum creatinine (mg/dL) · kidney transplant recipients

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 272 participants
Low

Angiotensin‐converting enzyme inhibitors vs placebo/no treatment

Haemoglobin (g/dL) · kidney transplant recipients

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 191 participants
Moderate

Angiotensin‐converting enzyme inhibitors vs placebo/no treatment

Blood pressure · kidney transplant recipients

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 392 participants
Very low

Angiotensin‐converting enzyme inhibitors vs calcium channel blockers

Death · kidney transplant recipients

ACE Inhibitors showed no clear difference in death compared with calcium channel blockers (low certainty).

1 finding from 1 review

Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
RR 4.03 [0.45, 35.82]
2 studies · 221 participants
Low